Mass Spectrometry has played an important role in protein biomarker discovery. However, only about dozen MS protein tests have been translated into clinical laboratories since the MALDI and ESI MS approaches were developed thirty years ago. While the cost and complexity of these assays are important factors impeding their clinical adoption, the new content generated via proteoforms detection could provide the impetus for further development and translation. Isoformix is developing a suite of MS protein tests targeting specific protein biomarkers that exhibit clinically significant proteoforms. These tests will be run on MS systems with sufficient sensitivity, resolution, and throughput for fully automated analyses. The new content brought by the detection of proteoforms will drive the proliferation of these MS tests - first in clinical utility studies and then for routine diagnostics. Copyright © 2018 Isoformix - All Rights Reserved.
| Website | http://www.isoformix.com |
| Revenue | $1 million |
| Employees | View employees |
| Address | 9830 S 51st St Ste B113, Phoenix, Arizona 85044, US |
| Phone | +1 480-777-7570 |
| Industry | Business Services General, Business Services |
| Competitors | Siemens, GE, Honeywell, Thermo Fisher Scientific, Emerson, Parker Hannifin, AMETEK, Molex, Watlow, Sierra Instruments +45 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Isoformix employee's phone or email?
Isoformix Questions
The Isoformix annual revenue was $1 million in 2026.
Isoformix is based in Phoenix, Arizona.
The NAICS codes for Isoformix are [541713, 541, 54, 5417, 54171].
The SIC codes for Isoformix are [87, 873].
